Safety Shot Inc (SHOT)
NASDAQ: SHOT · IEX Real-Time Price · USD
2.475
+0.105 (4.43%)
Mar 28, 2024, 10:19 AM EDT - Market open
Company Description
Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property.
Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema.
The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023.
The company was incorporated in 2018 and is headquartered in Jupiter, Florida.
Safety Shot Inc
Country | United States |
Founded | 2018 |
IPO Date | Oct 30, 2020 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 10 |
CEO | Jarrett Boon |
Contact Details
Address: 1061 E. Indiantown Rd., Ste. 110 Jupiter, Florida 33477 United States | |
Phone | 561-325-0482 |
Website | jupiterwellness.com |
Stock Details
Ticker Symbol | SHOT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $7.50 |
CIK Code | 0001760903 |
ISIN Number | US48208F1057 |
Employer ID | 83-2455880 |
SIC Code | 2844 |
Key Executives
Name | Position |
---|---|
Brian Scott John | Advisor |
Jarrett Boon | Chief Executive Officer and Director |
Jordan Schur | President and Director |
Danielle De Rosa-Diaz | Chief Financial Officer |
Anthony Pedicelli | Director of Marketing |
Dr. Andy Goren M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
David Sandler CSCS, FISSN, FNSCA, HFD, HFS, M.S., MS, RSCC | Chief Manufacturing Officer |
Josh Wagner | Chief Revenue Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 20, 2024 | 8-K | Current Report |
Mar 19, 2024 | 8-K | Current Report |
Mar 18, 2024 | 8-K | Current Report |
Mar 13, 2024 | 8-K | Current Report |
Mar 13, 2024 | 8-K | Current Report |
Mar 4, 2024 | 8-K | Current Report |
Mar 1, 2024 | 8-K | Current Report |
Feb 28, 2024 | 8-K | Current Report |
Feb 27, 2024 | 8-K | Current Report |
Feb 22, 2024 | 8-K | Current Report |